MSH6 and Familial prostate cancer: We therefore conclude that the private mutation in MSH6 may have led to spatial MSI and a consecutively increased mutation rate, which is in line with a study on prostate cancer, where somatic mutations in MSH6 have been associated with hypermutation [24].